<DOC>
	<DOCNO>NCT01210261</DOCNO>
	<brief_summary>Obstructive sleep apnea ( OSA ) condition disorder breathe characterise intermittent partial and/or complete upper airway obstruction sleep . The participant , naive nasal continuous positive airway pressure ( CPAP ) , recently diagnose OSA , undergo two automatic CPAP titration study collection polysomnographic ( PSG ) data . The data analyse assess effectiveness Compumedics auto-CPAP device normalisation sleep disorder breathe OSA patient , respect another auto-CPAP device .</brief_summary>
	<brief_title>New Versus Existing Auto-titrating CPAP Device Treat Obstructive Sleep Apnea Adults</brief_title>
	<detailed_description>Auto-titrating CPAP ( APAP ) use algorithm base detection flow limitation snore develop . Auto-titration device adjust nasal pressure minimum pressure need maintain airway patency point time accommodate range background state affect airway collapsibility hence CPAP pressure requirement include sedation , alcohol , airway inflammation , body position sleep state . Compumedics Limited developed APAP device ( Somnilink SPAP base new algorithm technology characterise breath determination inspiratory flow limitation . The objective new technology enable accurate detection inspiratory interval irregular breathing pattern likely occur REM sleep , sleep onset wakefulness well provide correct characterisation inspiratory flow limitation . These feature could translate delivery superior treatment improved sensitivity specificity respiratory event detection earlier pressure response inspiratory flow limitation . Demonstration superiority Somnilink SPAP device relative exist APAP treatment device subject future clinical trial ( beyond scope protocol ) . An early clinical trial pre-production version Somnilink SPAP pressure control algorithm identical production version establish non-inferiority AHI relative reference APAP ( Resmed Autoset Spirit ) differential AHI estimate -0.91 [ -2.80 ; 0.91 ] ( Mean [ 95 % CI ] ) . The Somnilink SPAP device available production version ( CE TGA approve ) purpose current study establish non-inferiority compare exist APAP device ( Resmed Autoset S8 ) . The treatment administer two night polysomnographic study ( PSG ) mean continuous air pressure delivery variable pressure level determine APAP device maintain upper airway patency . The population adult patient newly diagnose OSA undergoing diagnostic PSG study sleep laboratory previous CPAP treatment experience comply eligibility criterion ( outline ) study .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Age great 18 . Ability give inform consent . OSA diagnosis referral clinical CPAP implementation Monash Sleep Centre within 3 month recruitment . Inability give inform consent . Significant central sleep apnea ( AHI central event &gt; = 5 ) . Congestive heart failure . Coexisting obesity relate hypoventilation . Nasal obstruction , mouth breathe anatomical physiological condition make CPAP therapy inappropriate . History prior CPAP treatment . Previous reaction skin preparation , tape electrode gel use PSG .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>OSA</keyword>
	<keyword>CPAP</keyword>
	<keyword>APAP</keyword>
	<keyword>SPAP</keyword>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Sleep Apnea</keyword>
</DOC>